Additionally, focusing on the CD8+ T-cell clones that were cultured to sufficient numbers for further testing, we show that 3/6 tumor-reactive clones were more activated when cocultured with tumor cells treated with DAC compared to untreated cells (Figure 5). This evidence concerns the gene CD8A and neoplasm.